ArticleFrontiers in immunology2021

The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity.

Carlos Del Fresno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.